104 related articles for article (PubMed ID: 29170052)
1. Impact of age on survival of patients with pancreatic cancer after surgery: Analysis of SEER data.
Li X; Liu Z; Ye Z; Gou S; Wang C
Pancreatology; 2018 Jan; 18(1):133-138. PubMed ID: 29170052
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes for anaplastic pancreatic cancer: a population-based study.
Clark CJ; Graham RP; Arun JS; Harmsen WS; Reid-Lombardo KM
J Am Coll Surg; 2012 Nov; 215(5):627-34. PubMed ID: 23084492
[TBL] [Abstract][Full Text] [Related]
3. The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
Jeon CY; Pandol SJ; Wu B; Cook-Wiens G; Gottlieb RA; Merz CN; Goodman MT
PLoS One; 2015; 10(4):e0121783. PubMed ID: 25830309
[TBL] [Abstract][Full Text] [Related]
4. Conditional survival analysis for patients with intraductal papillary mucinous neoplasms (IPMNs) undergoing curative resection.
Gaitanidis A; Alevizakos M; Tsaroucha A; Tsalikidis C; Simopoulos C; Pitiakoudis M
Eur J Surg Oncol; 2018 May; 44(5):693-699. PubMed ID: 29426780
[TBL] [Abstract][Full Text] [Related]
5. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumor grade on pancreatic cancer prognosis: validation of a novel TNMG staging system.
Rochefort MM; Ankeny JS; Kadera BE; Donald GW; Isacoff W; Wainberg ZA; Hines OJ; Donahue TR; Reber HA; Tomlinson JS
Ann Surg Oncol; 2013 Dec; 20(13):4322-9. PubMed ID: 23943022
[TBL] [Abstract][Full Text] [Related]
7. Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis.
He C; Zhang Y; Cai Z; Lin X
BMC Cancer; 2019 May; 19(1):509. PubMed ID: 31142278
[TBL] [Abstract][Full Text] [Related]
8. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma.
Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA
Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697
[TBL] [Abstract][Full Text] [Related]
9. County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma.
Swords DS; Mulvihill SJ; Brooke BS; Stoddard GJ; Firpo MA; Scaife CL
Ann Surg; 2020 Dec; 272(6):1102-1109. PubMed ID: 30973391
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
Fukumoto T; Watanabe T; Hirai I; Kimura W
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):472-9. PubMed ID: 27246905
[TBL] [Abstract][Full Text] [Related]
11. Marital status and survival in pancreatic cancer patients: a SEER based analysis.
Baine M; Sahak F; Lin C; Chakraborty S; Lyden E; Batra SK
PLoS One; 2011; 6(6):e21052. PubMed ID: 21698253
[TBL] [Abstract][Full Text] [Related]
12. Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.
Ansari D; Bauden M; Bergström S; Rylance R; Marko-Varga G; Andersson R
Br J Surg; 2017 Apr; 104(5):600-607. PubMed ID: 28177521
[TBL] [Abstract][Full Text] [Related]
13. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
14. The impact of different metastatic patterns on survival in patients with pancreatic cancer.
He C; Huang X; Zhang Y; Lin X; Li S
Pancreatology; 2021 Apr; 21(3):556-563. PubMed ID: 33518454
[TBL] [Abstract][Full Text] [Related]
15. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
[TBL] [Abstract][Full Text] [Related]
16. Preoperative cognitive function predicts survival in patients with resectable pancreatic ductal adenocarcinoma.
Baekelandt BM; Hjermstad MJ; Nordby T; Fagerland MW; Kure EH; Heiberg T; Buanes T; Labori KJ
HPB (Oxford); 2016 Mar; 18(3):247-54. PubMed ID: 27017164
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
18. Perioperative outcomes and survival in elderly patients undergoing laparoscopic distal pancreatectomy.
Sahakyan MA; Edwin B; Kazaryan AM; Barkhatov L; Buanes T; Ignjatovic D; Labori KJ; Røsok BI
J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):42-48. PubMed ID: 27794204
[TBL] [Abstract][Full Text] [Related]
19. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
20. Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
Abe T; Amano H; Hanada K; Minami T; Yonehara S; Hattori M; Kobayashi T; Fukuda T; Nakahara M; Ohdan H; Noriyuki T
Anticancer Res; 2017 Oct; 37(10):5863-5870. PubMed ID: 28982913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
